| Parent Terms |
Term With Siblings |
Child Terms |
|
|
(1E)-2-(5-chlorothiophen-2-yl)-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}prop-1-ene-1-sulfonamide
(2R)-N-hydroxy-2-[(3S)-3-methyl-3-\{4-[(2-methylquinolin-4-yl)methoxy]phenyl\}-2-oxopyrrolidin-1-yl]propanamide
(2S)-2-[(3S)-3-\{[(6-chloronaphthalen-2-yl)sulfonyl]amino\}-2-oxopyrrolidin-1-yl]-N-(1-methylethyl)-N-\{2-[(methylsulfonyl)amino]ethyl\}propanamide
(2S)-N-((1S,2R)-2-hydroxy-1-(4-hydroxybenzyl)-3-\{[(8S,11S)-8-[(1S)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino\}propyl)-3-methyl-2-(2-oxopyrrolidin-1-yl)butanamide
(3S)-1-cyclohexyl-N-(3,5-dichlorophenyl)-5-oxopyrrolidine-3-carboxamide
(3S)-3-[(2S)-2-amino-3-hydroxybutyl]pyrrolidin-2-one
(3S)-3-[(2S)-2-amino-3-oxobutyl]pyrrolidin-2-one
(3S)-3-[(2S)-2-amino-4-hydroxy-3-oxobutyl]pyrrolidin-2-one
(3S)-N-(3-bromophenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide
(3S)-N-(3-chloro-2-methylphenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide
(3S)-N-(5-chloro-2-methylphenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide
(4-chloro-2-methylphenoxy)acetic acid
(beta-D-glucosyl)-O-mycofactocinone +
(E)-2-(5-chlorothiophen-2-yl)-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}ethenesulfonamide
(trifluoromethyl)benzene +
1,1-diunsubstituted alkanesulfonate +
1,2,5,6,9,10-hexabromocyclododecane
1,5,5-trimethylpyrrolidin-2-one
1-(3-(trifluoromethyl)phenyl)piperazine +
1-(3-chlorophenyl)piperazine
1-(4-carboxy-2-guanidinophenyl)-5,5-bis(hydroxymethyl)pyrrolidin-2-one
1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-one
1-chloro-2,2-bis(4'-chlorophenyl)ethylene
1-dodecylpyrrolidin-2-one
2-(3-hydroxyoctyl)-5-oxo-1-pyrrolidineheptanoic acid
2-(5-chlorothiophen-2-yl)-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}ethanesulfonamide
2-methyl-4-chlorophenoxybutyric acid
3,3-diethyl-2-pyrrolidinone
3,5-dibromo-4-hydroxybenzonitrile
3-(\{[(2S)-5-oxopyrrolidin-2-yl]methyl\}sulfonyl)-N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-L-alanin[N-(1-cyanocyclopropyl)]amide
3-(Dichloromethylene)-2,5-pyrrolidinedione
3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one
3-aminopropanesulfonic acid
3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-\{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl\}-L-phenylalaninamide
3-iodoprop-2-yn-1-yl butylcarbamate
3-nitro-4-(2-oxopyrrolidin-1-yl)benzenesulfonamide
3-oxo-N-[(3S)-2-oxopyrrolidin-3-yl]dodecanamide
4,5-dichloro-2-n-octyl-3(2H)-isothiazolone
4-[(2R)-2-(aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-yl]-3-[(1-ethylpropyl)amino]benzoic acid
4-aminobenzenesulfonic acid
4-hydroxy-3-[2-oxo-3-(thieno[3,2-b]pyridine-2-sulfonylamino)pyrrolidin-1-ylmethyl]benzamidine
5,7-dihydroxy-4'-methoxyflavone +
5-(5-chlorothiophen-2-yl)-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}-1H-1,2,4-triazole-3-sulfonamide
5-[(4-hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one
5-\{[(2-amino-9H-purin-6-yl)oxy]methyl\}pyrrolidin-2-one
5-chloro-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}-1-benzothiophene-2-sulfonamide
5-chloro-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}-1H-indole-2-sulfonamide
5-chlorospiro[indole-3,2'-[1,3]oxathiolan]-2(1H)-one
5-cyclohexylmethyl-2-Pyrrolidinone
5-methyl-1H-benzotriazole
5-oxopyrrolidine-2-carbaldehyde
5alpha-dihydrodeoxycorticosterone
6-chloro-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}-1-benzothiophene-2-sulfonamide
6-chloro-N-\{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl\}naphthalene-2-sulfonamide
6-methoxy-2-benzoxazolinone
6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole +
6:2 fluorotelomer unsaturated carboxylic acid
6alpha-methylprednisolone +
8:2 fluorotelomer unsaturated carboxylic acid
atorvastatin calcium trihydrate
bis(2-butoxyethyl)phthalate
bisperfluorodecyl phosphate
bisperfluorooctyl phosphate
chloromethylisothiazolinone +
decylamine-N,N-dimethyl-N-oxide
environmental food contaminant +
ethyl (2E,4S)-4-[((2R)-2-\{[N-(tert-butoxycarbonyl)-L-valyl]amino\}-2-phenylethanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate
ethyl (4R)-4-[((2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-\{[(5-methylisoxazol-3-yl)carbonyl]amino\}-4-oxoheptanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate
hexafluoropropylene oxide trimer acid
keto-D-fructose 1,6-bisphosphate
levetiracetam A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine.
metformin hydrochloride +
mono(5-carboxy-2-ethylpentyl) phthalate
N-(3-acetamidopropyl)pyrrolidin-2-one
N-(3-furoyl)-D-valyl-L-valyl-N-((1R,2Z)-4-ethoxy-4-oxo-1-\{[(3S)-2-oxopyrrolidin-3-yl]methyl\}but-2-enyl)-D-leucinamide
N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-\{(2S,3E)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl\}-L-leucinamide
N-[(2S)-3-cyclohexyl-1-oxo-1-(\{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl\}amino)propan-2-yl]-1H-indole-2-carboxamide
N-[(3S,6R)-6-\{(S,E)-4-ethoxycarbonyl-1-[(S)-2-oxopyrrolidin-3-yl]but-3-en-2-ylcarbamoyl\}-2,9-dimethyl-4-oxodec-8-en-3-yl]-5-methylisoxazole-3-carboxamide
N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-\{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl\}-L-leucinamide
N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N(1)-((1S)-4-ethoxy-4-oxo-1-\{[(3S)-2-oxopyrrolidin-3-yl]methyl\}but-2-enyl)-L-leucinamide
N-[(benzyloxy)carbonyl]-O-(tert-butyl)-L-threonyl-3-cyclohexyl-N-[(1S)-2-hydroxy-1-\{[(3S)-2-oxopyrrolidin-3-yl]methyl\}ethyl]-L-alaninamide
N-\{(3S)-1-[(1-aminoisoquinolin-7-yl)methyl]-2-oxopyrrolidin-3-yl\}thieno[3,2-b]pyridine-2-sulfonamide
N-ethylperfluorooctane sulfonamidoacetic acid
N-methylperfluorooctane sulfonamidoacetic acid
naphthalene-2,7-disulfonic acid
naphthalene-2-sulfonic acid
neohesperidin dihydrochalcone
perfluorooctane sulfonamidoacetic acid
persistent organic pollutant +
pyrrolidine dithiocarbamate
Sirius red 4B (acid form)
sodium meclofenamate monohydrate
systemic acquired resistance inducing compounds
tert-butyl N-\{1-[(1S)-1-\{[(1R,2S)-1-(benzylcarbamoyl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]carbamoyl\}-2-cyclopropylethyl]-2-oxopyridin-3-yl\}carbamate
trans-3-hydroxycotinine +
trans-3-hydroxycotinine beta-D-glucuronide
tris(2-butoxyethyl) phosphate
xenobiotic organic ethers
|
|
 |
| Synonyms |
| Exact Synonyms: |
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
|
| Related Synonyms: |
(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
;
Formula=C8H14N2O2
;
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
;
InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N
;
Keppra
;
SMILES=CC[C@H](N1CCCC1=O)C(N)=O
;
UCB-L 059
;
levetiracetamum
|
| Xrefs: |
CAS:102767-28-2
;
DrugBank:DB01202
;
Drug_Central:1563
;
KEGG:C07841
;
KEGG:D00709
;
LINCS:LSM-5603
|
| Xref Mesh: |
MESH:D000077287
|
| Xrefs: |
PMID:22119754
;
PMID:22321334
;
Reaxys:8407472
;
VSDB:2979
;
Wikipedia:Levetiracetam |
|
